Duloxetine Hcl Capsule, Delayed Release
Product Images NDC 80425-0146

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Duloxetine Hcl (NDC 80425-0146). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Duloxetine HCl Dr 30mg Cap Qty 60 Ndc 80425 0146

This is a label of a medication package containing Duloxetine HCLDR 30mg. The package includes 260 capsules grouped in 10 containers, and it was packed by AAdvancnd.*

FDA Label Image

Duloxetine HCl Dr 30mg Cap Qty 30 Ndc 80425 0146

This is a label from a package of Duloxetine HCL DR 30mg capsules, but it doesn't provide further information.*

FDA Label Image

Image 10

This is a description of medical treatment involving the drug Duloxetine. The dosage is given as 60/120 mg to be taken once a day. The document includes a graph charting "Percent Improvement in Pain from Baseline (BOCF)" over time. There is also a mention of "Placebo".*

FDA Label Image

Image 2

FDA Label Image

Image 6

FDA Label Image

Image 8

This appears to be a medication regimen for a drug called Duloxetine, to be taken once daily in 60 or 120 mg doses. The word "Placebo" at the beginning suggests that this was part of a clinical trial comparing the drug to a placebo. The rest of the text is unreadable or nonsensical.*

FDA Label Image

Image

FDA Label Image

Image3

This appears to be a graph showing the proportion of patients with relapse over time, categorized by treatment (placebo or duloxetine). The graph suggests that duloxetine may be more effective at preventing relapse than a placebo.*

FDA Label Image

Image4

The text is a table showing the percentage of patient improvement with different doses of Duloxetine compared to placebo. It also includes the percentage improvement in pain from the baseline.*

FDA Label Image

Image5

This appears to be a graph or chart indicating the percentage of patients who improved on different medications. It compares the effectiveness of Duloxetine when taken twice daily versus once daily, as well as a placebo. The chart also indicates the percentage improvement in pain from each medication compared to the baseline.*

FDA Label Image

Image7

FDA Label Image

Image9

This text appears to be a chart displaying the percent improvement in pain from baseline for a treatment of Placebo and Duloxetine 60 mg once daily. There is also some illegible text and numbers that cannot be deciphered.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.